RXDX Annual Working Capital
$685.33 M
+$436.39 M+175.30%
31 December 2022
Summary:
As of February 5, 2025, RXDX annual working capital is $685.33 million, with the most recent change of +$436.39 million (+175.30%) on December 31, 2022. During the last 3 years, it has risen by +$679.68 million (+12012.65%).RXDX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RXDX Quarterly Working Capital
$707.06 M
+$21.73 M+3.17%
31 March 2023
Summary:
As of February 5, 2025, RXDX quarterly working capital is $707.06 million, with the most recent change of +$21.73 million (+3.17%) on March 31, 2023. Over the past year, it has increased by +$489.40 million (+224.85%).RXDX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RXDX Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +175.3% | +224.8% |
| 3 y3 years | +10000.0% | - |
| 5 y5 years | +10000.0% | - |
RXDX Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | at high | at high |
Prometheus Biosciences Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $707.06 M(+3.2%) |
| Dec 2022 | $685.33 M(+175.3%) | $685.33 M(+182.9%) |
| Sept 2022 | - | $242.28 M(+19.4%) |
| June 2022 | - | $202.88 M(-6.8%) |
| Mar 2022 | - | $217.66 M(-12.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $248.94 M(+489.9%) | $248.94 M(-8.5%) |
| Sept 2021 | - | $272.01 M(-7.4%) |
| June 2021 | - | $293.89 M(-5.1%) |
| Mar 2021 | - | $309.83 M(+634.2%) |
| Dec 2020 | $42.20 M(+645.9%) | $42.20 M |
| Dec 2019 | $5.66 M | - |
FAQ
- What is Prometheus Biosciences annual working capital?
- What is the all time high annual working capital for Prometheus Biosciences?
- What is Prometheus Biosciences annual working capital year-on-year change?
- What is Prometheus Biosciences quarterly working capital?
- What is the all time high quarterly working capital for Prometheus Biosciences?
- What is Prometheus Biosciences quarterly working capital year-on-year change?
What is Prometheus Biosciences annual working capital?
The current annual working capital of RXDX is $685.33 M
What is the all time high annual working capital for Prometheus Biosciences?
Prometheus Biosciences all-time high annual working capital is $685.33 M
What is Prometheus Biosciences annual working capital year-on-year change?
Over the past year, RXDX annual working capital has changed by +$436.39 M (+175.30%)
What is Prometheus Biosciences quarterly working capital?
The current quarterly working capital of RXDX is $707.06 M
What is the all time high quarterly working capital for Prometheus Biosciences?
Prometheus Biosciences all-time high quarterly working capital is $707.06 M
What is Prometheus Biosciences quarterly working capital year-on-year change?
Over the past year, RXDX quarterly working capital has changed by +$489.40 M (+224.85%)